Sex: U
Vaccine: COVID19-2
Symptoms: Incorrect route of product administration, No adverse event, Wrong product administered
Clinical narrative: Moderna Covid-19 vaccine (bivalent) was mistaken as Lidocaine and was inadvertently administered to a patient who was going to have a lesion excised on the left upper arm; The vaccine was given subcutaneously; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Moderna Covid-19 vaccine (bivalent) was mistaken as Lidocaine and was inadvertently administered to a patient who was going to have a lesion excised on the left upper arm), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (The vaccine was given subcutaneously) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No medical history information was provided.  Concomitant products included LIDOCAINE (EXYGRA [LIDOCAINE]) and EPINEPHRINE (BOSMIN [EPINEPHRINE]) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Subcutaneous) .5 milliliter. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Moderna Covid-19 vaccine (bivalent) was mistaken as Lidocaine and was inadvertently administered to a patient who was going to have a lesion excised on the left upper arm), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (The vaccine was given subcutaneously) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Moderna Covid-19 vaccine (bivalent) was mistaken as Lidocaine and was inadvertently administered to a patient who was going to have a lesion excised on the left upper arm), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (The vaccine was given subcutaneously) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Subcutaneous), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (Moderna Covid-19 vaccine (bivalent) was mistaken as Lidocaine and was inadvertently administered to a patient who was going to have a lesion excised on the left upper arm) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (The vaccine was given subcutaneously).    It was reported that Moderna Covid-19 vaccine (bivalent) was mistaken as Lidocaine and was inadvertently administered to a patient who was going to have a lesion excised on the left upper arm. They had the vaccine in the room which was supposed to be given to the patient at the end of the procedure. Instead of the Lidocaine with epinephrine to be given to locally numb the area of the excision, the vaccine was the one that was given. The vaccine was given subcutaneously at 0.5 ml while the compound lidocaine and epinephrine (2%) was given anywhere between 1-3ml within 1-10 minutes after the Covid- 19 administration. No treatment drug details was reported.